Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Avalo Therapeutics, Inc. | Director | Common Stock | 1K | $13K | $13.00 | Nov 13, 2024 | By Meadowlark Management, LLC |
BRAINSTORM CELL THERAPEUTICS INC. | Director | Common Stock | 7.18K | $12.7K | $1.77 | Dec 15, 2021 | By Meadowlark Management LLC |
BRAINSTORM CELL THERAPEUTICS INC. | Director | Common Stock | 6K | $10.6K | $1.77 | Dec 15, 2021 | Direct |
Avalo Therapeutics, Inc. | Director | Restricted Stock Units | 9.5K | $4.93K | $0.52 | Aug 13, 2024 | Direct |
Actinium Pharmaceuticals, Inc. | Director | Stock Option (Right to Buy) | 50K | Nov 1, 2024 | Direct | ||
Avalo Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 24.6K | Aug 13, 2024 | Direct | ||
TENAX THERAPEUTICS, INC. | Director | Stock Option (right to buy) | 5K | Jun 9, 2022 | Direct |